OBJECTIVE: Studies show a high potential demand for psychiatric advance directives but low completion rates. The authors conducted a randomized study of a structured, manualized intervention to facilitate completion of psychiatric advance directives. METHOD: A total of 469 patients with severe mental illness were randomly assigned to a facilitated psychiatric advance directive session or a control group that received written information about psychiatric advance directives and referral to resources in the public mental health system. Completion of an advance directive, its structure and content, and its short-term effects on working alliance and treatment satisfaction were recorded. RESULTS: Sixty-one percent of participants in the facilitated session completed an advance directive or authorized a proxy decision maker, compared with only 3% of control group participants. Psychiatrists rated the advance directives as highly consistent with standards of community practice. Most participants used the advance directive to refuse some medications and to express preferences for admission to specific hospitals and not others, although none used an advance directive to refuse all treatment. At 1-month follow-up, participants in the facilitated session had a greater working alliance with their clinicians and were more likely than those in the control group to report receiving the mental health services they believed they needed. CONCLUSIONS: The facilitation session is an effective method of helping patients complete psychiatric advance directives and ensuring that the documents contain useful information about patients' treatment preferences. Achieving the promise of psychiatric advance directives may require system-level policies to embed facilitation of these instruments in usual-care care settings.
RCT Entities:
OBJECTIVE: Studies show a high potential demand for psychiatric advance directives but low completion rates. The authors conducted a randomized study of a structured, manualized intervention to facilitate completion of psychiatric advance directives. METHOD: A total of 469 patients with severe mental illness were randomly assigned to a facilitated psychiatric advance directive session or a control group that received written information about psychiatric advance directives and referral to resources in the public mental health system. Completion of an advance directive, its structure and content, and its short-term effects on working alliance and treatment satisfaction were recorded. RESULTS: Sixty-one percent of participants in the facilitated session completed an advance directive or authorized a proxy decision maker, compared with only 3% of control group participants. Psychiatrists rated the advance directives as highly consistent with standards of community practice. Most participants used the advance directive to refuse some medications and to express preferences for admission to specific hospitals and not others, although none used an advance directive to refuse all treatment. At 1-month follow-up, participants in the facilitated session had a greater working alliance with their clinicians and were more likely than those in the control group to report receiving the mental health services they believed they needed. CONCLUSIONS: The facilitation session is an effective method of helping patients complete psychiatric advance directives and ensuring that the documents contain useful information about patients' treatment preferences. Achieving the promise of psychiatric advance directives may require system-level policies to embed facilitation of these instruments in usual-care care settings.
Authors: Richard A Van Dorn; Marvin S Swartz; Eric B Elbogen; Jeffrey W Swanson; Mimi Kim; Joelle Ferron; Laura A McDaniel; Anna M Scheyett Journal: Adm Policy Ment Health Date: 2006-07
Authors: J P McEvoy; L J Apperson; P S Appelbaum; P Ortlip; J Brecosky; K Hammill; J L Geller; L Roth Journal: J Nerv Ment Dis Date: 1989-01 Impact factor: 2.254
Authors: Kiersten L Johnson; Sarah L Desmarais; Kevin J Grimm; Stephen J Tueller; Marvin S Swartz; Richard A Van Dorn Journal: Psychiatr Serv Date: 2016-02-29 Impact factor: 3.084
Authors: Sarah L Desmarais; Richard A Van Dorn; Kiersten L Johnson; Kevin J Grimm; Kevin S Douglas; Marvin S Swartz Journal: Am J Public Health Date: 2014-02-13 Impact factor: 9.308
Authors: Richard A Van Dorn; Sarah L Desmarais; Kevin J Grimm; Stephen J Tueller; Kiersten L Johnson; Brian G Sellers; Marvin S Swartz Journal: Psychiatry Res Date: 2016-08-09 Impact factor: 3.222
Authors: Graham Thornicroft; Simone Farrelly; Max Birchwood; Max Marshall; George Szmukler; Waquas Waheed; Sarah Byford; Graham Dunn; Claire Henderson; Helen Lester; Morven Leese; Diana Rose; Kim Sutherby Journal: Trials Date: 2010-11-05 Impact factor: 2.279